OmniAb, Inc. (OABI)

NASDAQ: OABI · USD

$5.26

+0.30 (+6.0%)· Recorded snapshot

Market cap	764M
Revenue (ttm)	38.5M
Net income (ttm)	-44.3M
EPS (ttm)	-$0.35
Shares out	145.4M
Volume	1,439,619
Beta	1.37

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 38.5M
Net income (ttm): -44.3M
EPS (ttm): -$0.35
Market cap: 764M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Halten

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-28 19:55 UTC

Forward P/En/a

P25 13.4P50 20.2P75 35.7

Trailing P/En/a

P25 15.4P50 25.8P75 43.5

ROE-17

P25 -113.8P50 -46.5P75 -0.9

ROIC-8.7

P25 -68.5P50 -27.1P75 1.8

Benchmarks · 1M

All OABI indicators

Market & fundamental data

Available fields

203

Groups with data

Currency

USD

Showing 203 of 203 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	USD
CIK code	0001846253
Company name	OmniAb, Inc.
Country	United States
Country code	US
CUSIP number	68218J103
Earnings date	2026-10-30
Earnings time	bmo
Employees	89
Employees change	-25
Employees growth	-21.93%
Enterprise value	$730.9M
Exchange	NASDAQ
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-09
Fiscal year end	December
Founded	2012
In index	RUSSELL2000
Industry	Biotechnology
Is primary listing	Yes
Is SPAC	No
ISIN number	US68218J1034
Last 10-K release date	2026-03-04
Last earnings date	2026-08-06
Last refreshed	2026-10-28
Last stock split type	Never
Market cap	$764M
Market cap category	Small-Cap
Next earnings date	2026-10-30
Options	Yes
Price	$5.26
Price currency	USD
Sector	Healthcare
SIC code	8731
Stock price date	2026-10-28
Symbol	OABI
U.S. state	California
Website	https://www.omniab.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings yield	-6.74%
EV/Sales	18.44x
FCF / EV yield	-2.56%
FCF yield	-2.44%
Forward EV/Sales	31.56x
Forward P/S	33.03x
P/B ratio	2.77x
P/S ratio	19.3x
Price / tangible book value	12.32x
Sector forward P/E	23.56x
Sector P/E	50.13x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	-101.74%
EBITDA margin	-56.16%
Gross margin	98.28%
Operating margin	-101.74%
Pretax margin	-118.86%
Profit margin	-115.12%
Profit per employee	$-497,416
Revenue per employee	$432,101
ROA	-8.35%
ROA (5Y)	-9.76%
ROCE	-14.15%
ROE	-16.95%
ROE (5Y)	-15.73%
ROIC	-8.69%
SBC / revenue	36.58%
Tax / revenue	-3.74%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth quarters	4
EPS growth years	1
Gross profit growth	66.04%
Gross profit growth (Q)	252.27%
Gross profit growth 3Y	-17.01%
Gross profit growth 5Y	10.19%
Net income growth quarters	2
Net income growth years	0
Revenue growth	67.01%
Revenue growth (Q)	244.24%
Revenue growth (QoQ)	-7.01%
Revenue growth 3Y	-16.53%
Revenue growth 5Y	10.57%
Revenue growth quarters	2
Revenue growth years	0

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	$-468,000
Depreciation and amortization	$17.5M
EBIT	$-39.1M
EBITDA	$-21.6M
EPS	$-0.35
FCF per share	$-0.12
Financing cash flow	$27.9M
Free cash flow	$-18.1M
Free cash flow minus SBC	$-32.2M
Gross profit	$37.8M
Income taxes	$-1.4M
Investing cash flow	$-4.1M
Net cash flow	$6.1M
Net income	$-44.3M
Operating cash flow minus SBC	$-31.7M
Operating income	$-39.1M
Revenue	$38.5M
Stock-based compensation	$14.1M

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	4.18
Book value per share	$1.79
Debt / equity	0.07
Goodwill	$84M
Long-term assets	$224.2M
Long-term liabilities	$16.2M
Net cash (debt)	$33.1M
Net cash / market cap	4.46%
Net cash growth	66.81%
Net debt / equity	-0.13
Piotroski F-Score	3
Property, plant and equipment	$22.9M
Shareholders' equity	$260.3M
Tangible book value	$60.2M
Tangible book value per share	$0.41
Total assets	$290.3M
Total cash	$52M
Total debt	$18.9M
Total liabilities	$30M
WACC	11.5%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.13
Current assets	$66M
Current liabilities	$13.8M
Current ratio	4.8
Net working capital	$4.2M
Quick ratio	4.53
Working capital	$52.3M
Working capital turnover	0.88

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	-19.28%
Dividend yield	0%
Shareholder yield	-19.28%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
150-day SMA	$2.95
1D price change	5.95%
1M price change	10.63%
1M total return	10.63%
1W price change	2.82%
1W total return	2.82%
1Y price change	220.76%
1Y return CAGR	221.01%
1Y total return	220.76%
20-day SMA	$4.76
200-day SMA	$2.67
3M price change	151.23%
3M total return	151.23%
3Y price change	13.84%
3Y return CAGR	4.41%
3Y total return	13.84%
50-day SMA	$4.61
50-day SMA vs 200-day SMA	50over200
52-week high	$5.43
52-week high date	2026-09-02
52-week low	$1.30
52-week low date	2025-11-05
6M price change	254.17%
6M total return	254.17%
All-time high	$10.50
All-time high date	2022-10-27
All-time low	$1.22
All-time low date	2025-05-30
Average true range (ATR)	$0.31
Average volume	1.3M
Beta (1Y)	1.81
Beta (2Y)	1.39
Beta (5Y)	1.37
Change from 52-week high	-3.22%
Change from 52-week low	304.23%
Change from all-time high	-51.43%
Change from all-time low	318.03%
Change from open	7.03%
Day's gap	-1.01%
Dollar volume	$7.6M
High price	$5.26
Low price	$4.91
Monthly RSI	65.37
Open price	$4.91
Position in 52-week range	98.57%
Premarket change	0.81%
Premarket close	$4.96
Premarket price	$5.00
Previous close	$4.96
Price vs 150-day SMA	72.65%
Price vs 20-day SMA	7.19%
Price vs 200-day SMA	91.08%
Price vs 50-day SMA	10.56%
Relative volume	1.07
RSI	60.51
Sharpe ratio	1.85
Sharpe ratio (3Y)	0.28
Sortino ratio	3.83
Sortino ratio (3Y)	0.55
Volume	1.4M
Weekly RSI	74.01
YTD price change	175.68%
YTD total return	175.68%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	118.2M
Float percentage	81.33%
Shares change (QoQ)	0.43%
Shares change (YoY)	19.28%
Shares held by insiders	11.62%
Shares held by institutions	40.4%
Shares outstanding	145.4M
Short % of float	6.93%
Short % of shares	5.64%
Short ratio	5.6 days

Deeper analysis on OABI

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this OABI report

Is a complete OABI research report available?

No complete published report is available for OmniAb, Inc. (OABI) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

OmniAb, Inc. (OABI)

Price

Financial snapshot

Fair-value bridge

Latest news · OABI

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All OABI indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on OABI

Frequently asked questions